论文部分内容阅读
糖尿病肾病(DN,dabetic nephropathy)是糖尿病慢性并发症之一,是导致糖尿病患者致死的重要原因。以往DN的诊断依赖临床蛋白尿的出现,但一旦进入该期,肾功能已不可逆转并且进行性恶化。因此早期诊断DN并进行干预治疗,无疑是十分必要的。综合评价“微量白蛋白尿(MAU,microalbuminuria)检测”是当前国内外公认的早期DN诊断指标。近年来许多报告认为MAU不仅是早期DN的一项主要指标,也是罹患大血管疾病一心血管疾病的危险信号。因此MAU是微血管病变大血管病变的一个窥视窗口,是早期干预治疗的标志。我院于1997年开展了微量白蛋
Diabetic nephropathy (DN), one of the chronic complications of diabetes, is an important cause of death in diabetic patients. The diagnosis of DN in the past relies on the appearance of clinical proteinuria, but once that period, renal function has become irreversible and progressive worsening. Therefore, early diagnosis of DN and intervention treatment is undoubtedly very necessary. Comprehensive evaluation “microalbuminuria (MAU) test ” is recognized at home and abroad early diagnosis of DN indicators. In recent years, many reports think that MAU is not only a major indicator of early stage DN, but also a danger signal of cardiovascular disease with cardiovascular disease. Therefore, MAU is a peep window of macroangiopathy in microangiopathy and is a sign of early intervention. Our hospital launched a trace of white eggs in 1997